Title:
BIOLOGICAL PRODUCT FOR PREVENTING NOVEL CORONAVIRUS
Document Type and Number:
WIPO Patent Application WO/2021/164097
Kind Code:
A1
Abstract:
Provided is a biological product for preventing a novel coronavirus (COVID-19). The biological product can be a gene vaccine or a gene medicine. The gene vaccine adopts a human adenovirus type 5 with deletion of E1 and E3 genes as a vector for carrying an S1 protein antigen expressing a Spike S1 subunit of the novel coronavirus or simultaneously carrying the S1 protein antigen and an N protein antigen, generating an immune response, and preventing novel coronavirus infection and transmission.
Inventors:
ZHANG SHUYUAN (CN)
XU WEI (CN)
XU WEI (CN)
Application Number:
PCT/CN2020/080861
Publication Date:
August 26, 2021
Filing Date:
March 24, 2020
Export Citation:
Assignee:
SYNO SHENZHEN BIOMEDICAL RES CO LTD (CN)
International Classes:
C07K19/00; A61K39/25; A61K48/00; C12N15/62; G01N33/569; A61P11/00
Foreign References:
| CN1562365A | 2005-01-12 |
Other References:
DATABASE GenBank NCBI; 11-02-2020, ANONYMOUS: "Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, co - Nucleotide - NCBI", XP055840040, Database accession no. MN908947.3
Attorney, Agent or Firm:
SHENZHEN ZHUOK INTELLECTUAL PROPERTY AGENT LIMITED (CN)
Download PDF: